INTERVENTIONS -EXERCISE
A Clinicians should use mechanical loading, which can be either in the form of eccentric exercise, or a heavy-load, slowspeed (concentric/eccentric) exercise program, to decrease pain and improve function for patients with midportion Achilles tendinopathy without presumed frailty of the tendon structure. 
INTERVENTIONS -STRETCHING
C Clinicians may use stretching of the ankle plantar flexors with the knee flexed and extended to reduce pain and improve satisfaction with outcome in patients with midportion Achilles tendinopathy who exhibit limited ankle dorsiflexion range of motion.
INTERVENTIONS -NEUROMUSCULAR RE-EDUCATION
F Clinicians may use neuromuscular exercises targeting lower extremity impairments that may lead to abnormal kinetics and/or kinematics, specifically eccentric overload of the Achilles tendon during weight-bearing activities.
INTERVENTIONS -MANUAL THERAPY
F Clinicians may consider using joint mobilization to improve mobility and function and soft tissue mobilization to increase range of motion for patients with midportion Achilles tendinopathy.
INTERVENTIONS -PATIENT EDUCATION: ACTIVITY MODIFICATION
B For patients with nonacute midportion Achilles tendinopathy, clinicians should advise that complete rest is not indicated and that they should continue with their recreational activity within their pain tolerance while participating in rehabilitation.
INTERVENTIONS -PATIENT COUNSELING
E Clinicians may counsel patients with midportion Achilles tendinopathy. Key elements of patient counseling could include (1) theories supporting use of physical therapy and role of mechanical loading, (2) modifiable risk factors, including body mass index and shoewear, and (3) typical time course for recovery from symptoms.
INTERVENTIONS -HEEL LIFTS
D Because contradictory evidence exists, no recommendation can be made for the use of heel lifts in patients with midportion Achilles tendinopathy.
INTERVENTIONS -NIGHT SPLINTS
C Clinicians should not use night splints to improve symptoms in patients with midportion Achilles tendinopathy.
INTERVENTIONS -ORTHOSES
D Because contradictory evidence exists, no recommendation can be made for the use of orthoses in patients with midportion Achilles tendinopathy.
INTERVENTIONS -TAPING
F Clinicians should not use therapeutic elastic tape to reduce pain or improve functional performance in patients with midportion Achilles tendinopathy.
F Clinicians may use rigid taping to decrease strain on the Achilles tendon and/or alter foot posture in patients with midportion Achilles tendinopathy.
INTERVENTIONS -LOW-LEVEL LASER THERAPY
D Because contradictory evidence exists, no recommendation can be made for the use of low-level laser therapy in patients with midportion Achilles tendinopathy.
INTERVENTIONS -IONTOPHORESIS
B Clinicians should use iontophoresis with dexamethasone to decrease pain and improve function in patients with acute midportion Achilles tendinopathy.
INTERVENTIONS -DRY NEEDLING
F Clinicians may use combined therapy of dry needling with injection under ultrasound guidance and eccentric exercise to decrease pain for individuals with symptoms greater than 3 months and increased tendon thickness.
Summary of Recommendations*
*These recommendations and clinical practice guidelines are based on the scientific literature published prior to November 2017.
The Orthopaedic Section of the American Physical Therapy Association (APTA) has an ongoing effort to create evidencebased clinical practice guidelines (CPGs) for orthopaedic physical therapy management of patients with musculoskeletal impairments described in the World Health Organization's International Classification of Functioning, Disability and Health (ICF).
The purposes of these clinical guidelines are to: • Describe evidence-based physical therapy practice, including diagnosis, prognosis, intervention, and assessment of outcome for musculoskeletal disorders commonly managed by orthopaedic physical therapists • Classify and define common musculoskeletal conditions using the World Health Organization's terminology related to impairments of body function and body structure, activity limitations, and participation restrictions • Identify interventions supported by current best evidence to address impairments of body function and structure, activity limitations, and participation restrictions associated with common musculoskeletal conditions • Identify appropriate outcome measures to assess changes resulting from physical therapy interventions in body function and structure as well as in activity and participation of the individual • Provide a description to policy makers, using internationally accepted terminology, of the practice of orthopaedic physical therapists
• Provide information for payers and claims reviewers regarding the practice of orthopaedic physical therapy for common musculoskeletal conditions • Create a reference publication for orthopaedic physical therapy clinicians, academic instructors, clinical instructors, students, interns, residents, and fellows regarding the best current practice of orthopaedic physical therapy
STATEMENT OF INTENT
These guidelines are not intended to be construed or to serve as a standard of medical care. Standards of care are determined on the basis of all clinical data available for an individual patient and are subject to change as scientific knowledge and technology advance and patterns of care evolve. These parameters of practice should be considered guidelines only. Adherence to them will not ensure a successful outcome in every patient, nor should they be construed as including all proper methods of care or excluding other acceptable methods of care aimed at the same results.
The ultimate judgment regarding a particular clinical procedure or treatment plan must be made based on clinician
Introduction
Content experts with relevant physical therapy, medical, and surgical expertise were appointed by the Orthopaedic Section, APTA to conduct a review of the literature and to develop an updated Achilles Pain, Stiffness, and Muscle Power Deficits: Midportion Achilles Tendinopathy CPG as indicated by the current state of the evidence in the field. The aims of the revision were to provide a concise summary of the evidence since publication of the original guideline and to develop new recommendations or revise previously published recommendations to support evidence-based practice. The authors of this guideline revision worked with the CPG Editors and medical librarians for methodological guidance. The research librarians were chosen for their expertise in systematic review and rehabilitation literature search and to perform systematic searches for concepts associated with classification, examination, and intervention strategies for Achilles Pain, Stiffness, and Muscle Power Deficits: Midportion Achilles Tendinopathy. 22 Briefly, the following databases were searched from 2009 to November 2017: MEDLINE, CINAHL, Cochrane Library, and PEDro (see APPENDIX A for full search strategies and APPENDIX B for search dates and results, available at www.orthopt.org).
The authors declared relationships and developed a conflict management plan, which included submitting a Conflict of Interest form to the Orthopaedic Section, APTA, Inc. Articles that were authored by a reviewer were assigned to an alternate reviewer. Funding was provided to the CPG development team for travel and expenses for CPG development training by the Orthopaedic Section, APTA, Inc. The CPG development team maintained editorial independence.
Articles contributing to recommendations were reviewed based on specified inclusion and exclusion criteria with the goal of identifying evidence relevant to physical therapist clinical decision making for adults with Achilles Pain, Stiffness, and Muscle Power Deficits: Midportion Achilles Tendinopathy. The title and abstract of each article were reviewed independently by 2 members of the CPG development team for inclusion (see APPENDIX C for inclusion and exclusion criteria, available at www.orthopt.org). Full-text review was then similarly conducted to obtain the final set of articles for contribution to recommendations. The team leader (R.L.M.) provided the final decision for discrepancies that were not resolved by the review team (see APPENDIX D for flow chart of articles and APPENDIX E for articles included in recommendations by topic, available at www.orthopt.org). For selected relevant topics that were not appropriate for the development of recommendations, such as incidence and imaging, articles were not subject to a systematic review process and were not included in the flow chart. Evidence tables for this CPG are available on the Clinical Practice Guidelines page of the Orthopaedic Section of the APTA website: www.orthopt.org.
This guideline was issued in 2018 based on the published literature up through November 2017. This guideline will be considered for review in 2022, or sooner if new evidence becomes available. Any updates to the guideline in the interim period will be noted on the Orthopaedic Section of the APTA website: www.orthopt.org.
LEVELS OF EVIDENCE
Individual clinical research articles were graded according to criteria adapted from the Centre for Evidence-Based Medicine, Oxford, United Kingdom for diagnostic, prospective, and therapeutic studies. 149 In teams of 2, each reviewer independently assigned a level of evidence and evaluated the quality of each article using a critical appraisal tool (see APPENDICES F and G for Levels of Evidence table and details on procedures used for assigning levels of evidence, available at www.orthopt.org). The evidence update was organized from highest level of evidence to lowest level. An abbreviated version of the grading system is provided below.
I
Evidence obtained from systematic reviews, high-quality diagnostic studies, prospective studies, or randomized controlled trials
II
Evidence obtained from systematic reviews, lesser-quality diagnostic studies, prospective studies, or randomized controlled trials (eg, weaker diagnostic criteria and reference standards, improper randomization, no blinding, less than 80% follow-up) III Case-control studies or retrospective studies IV Case series V Expert opinion
GRADES OF EVIDENCE
The strength of the evidence supporting the recommendations was graded according to the previously established methods for the original guideline and those provided below. Each team developed recommendations based on the strength of evidence, including how directly the studies addressed the question of Achilles Pain, Stiffness, and Muscle Power Deficits: Midportion Achilles Tendinopathy. In developing their recommendations, the authors considered the strengths and limitations of the body of evidence and the health benefits, side effects, and risks of tests and interventions.
Methods

GUIDELINE REVIEW PROCESS AND VALIDATION
Identified reviewers who are experts in Achilles tendinopathy management and rehabilitation reviewed the CPG draft for integrity, accuracy, and to ensure that it fully represented the current evidence for the condition. The guideline draft was also posted for public comment and review on www.orthopt.org, and a notification of this posting was sent to the members of the Orthopaedic Section, APTA, Inc. In addition, a panel of consumer/patient representatives and external stakeholders, such as claims reviewers, medical coding experts, academic educators, clinical educators, physician specialists, and researchers, also reviewed the guideline. All comments, suggestions, and feedback from the expert reviewers, public, and consumer/patient representatives were provided to the authors and editors for consideration and revisions. Guideline development methods, policies, and implementation processes are reviewed at least yearly by the Orthopaedic Section, APTA's ICF-Based Clinical Practice Guideline Advisory Panel, including consumer/ patient representatives, external stakeholders, and experts in physical therapy practice guideline methodology.
DISSEMINATION AND IMPLEMENTATION TOOLS
In addition to publishing these guidelines in the Journal of Orthopaedic & Sports Physical Therapy (JOSPT), these guidelines will be posted on CPG areas of both the JOSPT and the Orthopaedic Section, APTA websites, which are freeaccess website areas, and submitted to be available free access on the Agency for Healthcare Research and Quality's website (www.guideline.gov). The implementation tools planned to be available for patients, clinicians, educators, payers, policy makers, and researchers, and the associated implementation strategies, are listed in TABLE 1. 
Methods (continued)
D
Conflicting evidence
Higher-quality studies conducted on this topic disagree with respect to their conclusions. The recommendation is based on these conflicting studies
E
Theoretical/ foundational evidence A preponderance of evidence from animal or cadaver studies, from conceptual models/ principles, or from basic science/bench research support this conclusion
F
Expert opinion
Best practice based on the clinical experience of the guidelines development team
CLASSIFICATION
The terminology used to describe Achilles tendon disorders varies, with "tendinitis," "tendonitis," or "paratenonitis" commonly being used and therefore suggestive of an inflammatory condition. Because inflammation and degeneration are usually not mutually exclusive, 99, 111, 119, 150, 152 "midportion Achilles tendinopathy" will be the focus of this clinical guideline unless otherwise stated.
The International Classification of Diseases (ICD-10) code associated with Achilles tendinopathy is M76.6 Achilles tendinitis/Achilles bursitis. The corresponding primary ICD-9-CM code, commonly used in the United States, is 726.71 Achilles bursitis or tendinitis.
The primary ICF body function codes associated with Achilles tendinopathy are b28015 Pain in lower limb, b7300 Power of isolated muscles and muscle groups, and b7800 Sensation of muscle stiffness.
The primary ICF body structures codes associated with Achilles tendinopathy are s75012 Muscles of lower leg and s75028 Structure of ankle and foot, specified as Achilles tendon.
The primary ICF activities and participation codes associated with Achilles tendinopathy are d4500 Walking short distances, d4501 Walking long distances, d4552 Running, d4553 Jumping, and d9201 Sports.
A comprehensive list of codes was published in the previous guideline.
22
ORGANIZATION OF THE GUIDELINE
For each topic, the summary recommendation and grade of evidence from the 2010 guideline are presented, followed by a synthesis of the recent literature with the corresponding evidence levels. Each topic concludes with the 2018 summary recommendation and its updated grade of evidence.
Methods (continued)
PREVALENCE 2010 Summary
Disorders of the Achilles tendon rank among the most frequently reported overuse injuries in the literature. 30, 116, 128, 130 The majority of those suffering from Achilles tendinopathy are active individuals, often involved in recreational or competitive sports. 114 Estimates of the annual incidence of Achilles tendinopathy in runners range between 7% and 9%. 101, 114 However, cases have been reported in sedentary groups as well.
92, 164 Although runners appear to be the most commonly affected cohort, 114, 116, 118, 145 Achilles disorders have been reported in a wide variety of sports. 64, 68, 114, 116, 207 Athletes are more likely to become symptomatic when training as opposed to during competitive events. 101, 207 While there is an increased prevalence of Achilles injury as age increases, 64,113 the mean age of those affected by Achilles disorders is between 30 and 50 years.
130,148,167 While sex has not been directly studied, data from multiple works suggest that males are affected to a greater extent than females. 116, 145, 167 Evidence Update
I
The prevalence of Achilles tendinopathy in elite male soccer players during 1 season ranged from 2.1% to 5.1%.
76
I
In a large prospective cohort of novice runners, 7% went on to develop Achilles tendinopathy.
140
II
A systematic review by Sobhani et al 183 found Achilles tendinopathy to be one of the most common overuse foot and ankle injuries in sports. In a separate systematic review, the reported prevalence of Achilles tendinopathy in the general running and ultramarathon populations ranged from 6.2% to 9.5% and 2.0% to 18.5%, respectively.
122
II
Achilles tendinopathy was diagnosed in 1.8% of adolescent athletes at a pre-sports participation annual health examination.
23
II
The incidence of Achilles tendinopathy was found to be 1.85 per 1000 patients 43 and 2.16 per 1000 person-years 3 in Dutch general practice populations.
A review of more than 20 million patient records found that individuals between 40 and 59 years of age were most commonly diagnosed as having Achilles tendinopathy, with a significantly higher incidence than that seen in those between 20 and 39 and between 60 and 69 years of age. No difference in the incidence of Achilles tendinopathy was found between males and females. 211 
III
Achilles tendinopathy was found to occur in 12.5% of rock climbers.
19
Summary
Midportion Achilles tendinopathy continues to be a relatively common overuse lower extremity soft tissue injury for individuals who are active and participate in sports.
PATHOANATOMICAL FEATURES 2018 Summary and Update
The major complaint of those with midportion Achilles tendinopathy is pain that limits activity. Pain is preceded by an excessive mechanical stressor, such as tensile loading and/ or shearing, which initiates pathological changes in the tendon. 123 Systematic reviews have identified genetic variants as important factors in the pathogenesis of tendinopathy.
37,129 An abnormal neuronal phenotype can disrupt normal tendon homeostasis and healing after injury. 37 The neuronal response to tendon injury involves nerve ingrowth, increased sensitivity to neuronal pain mediators, and receptor activation for these mediators.
15,29,37,82,100 Neuronal changes activate the nociceptive pathways to higher centers and are responsible for the perception of pain. Therefore, altered central nervous system pain processing may also be an important factor in persistent tendon pain. 38, 89, 98, 182, 195 However, a recent study found that those with Achilles tendinopathy did not display significant features of central sensitization. 153 Genetic variants, such as those associated with mRNA stability, can predispose individuals to abnormalities in collagen production. 
RISK FACTORS 2010 Summary
For specific groups of individuals, clinicians should consider abnormal ankle dorsiflexion range of motion, abnormal subtalar joint range of motion, decreased ankle plantar flexion strength, increased foot pronation, and abnormal tendon structure as intrinsic risk factors associated with Achilles tendinopathy. Obesity, hypertension, hyperlipidemia, and diabetes are medical conditions associated with Achilles tendinopathy. Clinicians should also consider training errors, environmental factors, and faulty equipment as extrinsic risk factors associated with Achilles tendinopathy.
Evidence Update
I
A systematic review by Dowling et al 58 investigating dynamic foot function as a risk factor for lower-limb overuse injuries included only 1 study related to Achilles tendinopathy. This prospective study found altered posterior/anterior force displacement and an increase in laterally directed force distribution underneath the forefoot as risk factors for developing Achilles tendinopathy in runners who were noted to be "heel-strikers." 200 A prospective cohort study not included in this review found that runners who displayed more medial pressure during stance phase were at risk for injury.
18
II
Franceschi et al 69 identified obesity as a risk factor for developing tendinopathies in their systematic review.
A systematic review by McAuliffe et al 134 found that tendon abnormalities visualized using ultrasound imaging in asymptomatic tendons were predictive of future tendinopathy. Specifically, in athletes, increased tendon thickness 100 and sonographic abnormalities (moderate or severe hypoechoic defects) 31 were identified as risk factors for the development of Achilles tendinopathy.
A retrospective study investigated injuries in military recruits who were given either a rigid (n = 1416) or shock-absorbing (n = 1338) insole when issued combat boots. The recruits issued a shock-absorbing insole had a 50% reduction in Achilles tendinopathy rate, with an incidence of 4% compared to 8% with the rigid insoles.
93
III
A systematic review identified intrinsic risk factors for Achilles tendinopathy to include increasing age, male sex, increased body weight, poor tendon temperature regulation, presence of systemic diseases, decreased muscle strength, decreased flexibility, previous injuries, poor blood supply, and genetic variants. 129 One study in this review found those with a family history of tendinopathy to have 5 times the risk of developing Achilles tendinopathy. 110 
Systematic reviews found that gene variants influenced the development of Achilles tendinopathy. 108, 202 Specifically, genes associated with the collagen-production pathway may functionally affect tendon strength and stiffness, leading to an abnormal tendon response to loading. This was supported by other studies not included in this review.
75,157
III
A systematic review by Lorimer and Hume 123 found a posterior-directed center of force when landing, combined with reduced eccentric strength, as potential risk factors for Achilles injury, while having a high arch and generating high propulsion forces were found to be protective against injury.
Reviews have noted limited evidence for hip muscle performance as risk factors when generally looking at leg, ankle, and foot injuries. 138, 188 However, another review by Semciw et al 177 found neuromuscular deficits and extrinsic factors that lead to tendon overloading. The body's response to loading will be influenced by health conditions, drugs, and genetic factors. Consequently, many studies of eccentric loading have excluded patients with presumed tissue frailty (TABLE 2) . While these conditions are believed to increase risk during eccentric activity, the interactions between physical loads and tendon symptoms are poorly understood for these patients. Clinicians should consider these risk factors in the patient's differential diagnosis.
An individual with any number of lower extremity impairments that lead to abnormal kinetics and/or kinematics that specifically produce an eccentric overload of the Achilles tendon may be at risk for Achilles tendon injury. The use of shock-absorbing insoles may help prevent midportion Achilles tendinopathy.
CLINICAL COURSE 2010 Summary
No summary.
Evidence Update
I
In elite male soccer players, missed participation because of symptoms related to Achilles tendinopathy was relatively brief (median, 10 days; average, 23 days). However, recurrence rate was high (27%), with a greater risk of reinjury for players resting less than 10 days. In those with severe tendinopathies (more than 28 days lost), 38% required surgical intervention.
76
I
In a large prospective cohort of runners, the median time to recovery was 82 days (minimum, 21; maximum, 479). 140 in gluteus medius function in those with Achilles tendinopathy. A study not included in this review found weakness in the hip abductors, external rotators, and extensors bilaterally in recreational male athletes with chronic midportion Achilles tendinopathy. 86 Other studies have specifically identified neuromuscular deficits in the gluteus maximus, 70 rectus femoris, 214 tibialis anterior, 214 lateral gastrocnemius, 214 and triceps surae muscle complex 204 ; altered hip, knee, and ankle moments 105 ; altered hip biomechanics 34 ; increased lowerlimb stiffness 39 ; balance deficits 175 ; and abnormal lower extremity kinematics during dancing push-off maneuvers 115 as intrinsic risk factors.
III
In a sample of 24 elite, female soccer players, a sportspecific proprioception training program performed over a 2.5-year duration decreased the rate of Achilles tendinopathy and days lost from play due to injury. 109 
One study in the review by Franceschi et al 69 identified a potential interaction between age and obesity with degenerative tendon changes. 176 Those with dyslipidemia and fat deposition in the Achilles tendon may be at risk for developing tendon pain. 73 This finding is consistent with a systematic review that found that elevated adiposity was frequently associated with general tendon injuries.
74
III
A study of master track-and-field athletes did not find any influence of age, sex, weight, height, or participation in high-versus low-impact activities on the development of Achilles tendinopathy. 121 However, elderly individuals with diabetes who participated in sports were found to be at increased risk for Achilles tendinopathy. 
The review by Magnan et al 129 also identified extrinsic factors in the development of Achilles tendinopathy to include environmental conditions, shoes, equipment, surfaces, and physical activity/sport participation. One study of professional ballet dancers noted overuse injuries to be more common in females and in more technically demanding ballet techniques. 184 
Systematic reviews have specifically identified an increased risk of tendon injury with use of fluoroquinolone antibiotic therapy. 117, 120, 129, 189 IV A study included in above reviews found mitochondrial damage to tenocytes during fluoroquinolone treatment to be potentially involved in tendon pathology.
124
Summary
The risk of developing midportion Achilles tendinopathy is multifactorial and likely related to an interaction of intrinsic with an acute bout of activity and may increase after the activity. Symptoms are frequently accompanied by Achilles tendon tenderness, a positive arc sign, and positive findings on the Royal London Hospital test. These signs and symptoms are useful clinical findings for classifying a patient with ankle pain into the ICD category of Achilles bursitis or tendinitis and the associated ICF impairment-based category of Achilles pain (b28015 Pain in lower limb), stiffness (b7800 Sensation of muscle stiffness), and muscle power deficits (b7301 Power of muscles of lower limb).
Evidence Update
II
Hutchison et al 94 examined 21 participants with and without Achilles tendinopathy who underwent an ultrasound scan followed by 10 clinical tests for midportion Achilles tendinopathy. Subjective reporting of pain 2 to 6 cm proximal to the Achilles insertion, extending to the calcaneus (sensitivity, 84%; specificity, 73%; κ = 0.74-0.96), and pain with palpation of the midportion of the tendon (sensitivity, 78%; specificity, 77%; κ = 0.75-0.81) was found to be accurate and reliable in diagnosing midportion Achilles tendinopathy.
III
Reiman and colleagues 160 performed a systematic review and meta-analysis of the utility of current clinical measures for the diagnosis of Achilles tendon injuries. Because only 2 studies met the inclusion criteria, the authors determined that further high-quality studies are needed.
Recommendation
C
In addition to the arc sign and Royal London Hospital test, 127 clinicians can use a subjective report of pain located 2 to 6 cm proximal to the Achilles tendon insertion that began gradually and pain with palpation of the midportion of the tendon to diagnose midportion Achilles tendinopathy.
DIFFERENTIAL DIAGNOSIS 2010 Recommendation
See slightly modified recommendation below.
Evidence Update
IV
Using ultrasound scans in patients with pain in the Achilles tendon region, Morton and colleagues 137 identified tears in fascial tissue that divide the leg into its compartments.
The plantaris tendon may play a role in chronic midportion Achilles regional pain. A recent retrospective study examined the incidence of plantaris
II
The lack of uniformity in Achilles tendon structure on ultrasonography (hyperechogenicity/hypoechogenicity) is not a consistent predictor for outcome.
12,42
II
Sex may influence response to treatment with eccentric exercise, as females with Achilles tendinopathy perceived more pain and less of an improvement in function compared to males following 12 weeks of eccentric training. 107 
Good long-term outcomes were noted in 4.2-year 79 and 5-year 199 follow-up studies of individuals who completed a 3-month heavy-load eccentric calf muscle training program. However, mild pain persisted in some individuals, 199 and there was considerable variability in treatment outcomes.
71,130,168
III
A study of National Basketball Association players found that there was an association between Achilles tendinopathy and a decline in performance, with younger players having a better chance of returning to competition. 6 
Conflicting evidence related to body mass index (BMI) was identified. The systematic review by Franceschi et al 69 found that greater BMI played a role in the development of Achilles tendinopathy. However, a study in this review revealed that BMI did not influence response to nonsurgical treatment. 106 
IV
A case series by Silbernagel et al 182 found that 80% (27/34) of participants who completed a 12-week to 6-month progressive Achilles tendon-loading strengthening program were fully recovered at 5-year follow-up.
Summary
In athletes with midportion Achilles tendinopathy, missed participation can be expected to be brief. However, a decline in performance may occur in older athletes, and symptoms may return if not properly treated immediately after injury. Recovery time can vary from brief to many months and is probably dependent on the severity of the injury. Recovery may be influenced by intrinsic factors, such as sex. While most patients will improve, mixed levels of recovery can be anticipated.
DIAGNOSIS/CLASSIFICATION
2010 Recommendation C Self-reported localized pain and perceived stiffness in the Achilles tendon following a period of inactivity (eg, sleep, prolonged sitting) lessen dinopathy, with signs including increased tendon thickness (eg, anterior/posterior diameter or cross-sectional area), altered composition (eg, echogenicity on ultrasound and signal intensity on MRI), and/or neovascularization (eg, location and extent of activity on Doppler ultrasound). 9, 78, 143, 151, 191, 201, 208 However, there is conflicting evidence on the level of association between severity of tendon abnormalities and symptoms.
12,16,42,44,51,56,63,67,80,85,143,144, 162, 178, 187, 193, 201, 209, 210 There are techniques currently being developed using ultrasound elastography to estimate tissue mechanical properties (eg, strain and stiffness), which may provide greater insight into tendon pathology in the future.
77,90
Decision Tree Model
A pathoanatomical/medical diagnosis of midportion Achilles tendinopathy can provide valuable information in describing tissue pathology and may assist in planning treatment and predicting prognosis. The proposed model for examination, diagnosis, and treat ment planning for patients with Achilles pain, stiffness, and muscle power deficits associated with midportion Achilles tendinopathy uses the follow ing components: (1) medical screening, (2) classification of the condition through evaluation of clinical findings suggestive of musculoskeletal impairments of body function ing (ICF) and associated tissue pathology/disease (ICD, 3) determination of irritability stage, (4) determination of evaluative outcome measures, and (5) intervention strategies for patients in acute and nonacute stages. This model is depicted in the FIGURE.
Component 1
Medical screening incorporates the findings from the history and physical examination to determine whether the patient's symptoms originate from a condition that requires referral to another health care provider. Acute Achilles tendon rupture and systemic inflammatory disease would be examples of conditions that would require referral to another health care provider.
Component 2
Evaluation of physical examination findings, as outlined in the FIGURE, should be consistent with the diagnosis of midportion Achilles tendinopathy. The diagnosis and management of the patient's condition should be appropriately modified if the evaluation of clinical findings related to the musculoskeletal impairments of body functioning (ICF) and associated tissue pathology/disease (ICD) suggest other foot or ankle conditions in a differential diagnosis list, symptoms from the lumbopelvic region, or systemic or medical disease.
Component 3
Irritability is a term used by rehabilitation practitioners to reflect the tissue's ability to handle physical stress, 135 and is injuries in track-and-field athletes and found that plantaris injury occurred with an annual incidence of 3.9% to 9.3%.
154
V Dalbeth and colleagues 36 reported on the frequency and patterns of monosodium urate (MSU) crystal deposition in tendons and ligaments of patients with gout using dual-energy computed tomography (DECT). Ninety-two people with tophaceous gout had DECT scanning of both feet, with the Achilles tendon being the most common site of MSU crystal deposition.
and 2018 Summary
Clinicians should consider diagnostic classifications other than midportion Achilles tendinopathy, including involvement of the plantaris tendon, 154 when the patient's reported activity limitations or impairments of body function and structure are not consistent with those presented in the Diagnosis, Classification, and Clinical Course sections of this updated guideline, or when the patient's symptoms are not resolving with interventions aimed at normalization of the patient's impairments of body function.
The following conditions should be considered in the differential diagnosis of patients presenting with posterior ankle pain:
• Acute Achilles tendon rupture 
Update and Summary
Ultrasound imaging and MRI may be useful in assessing for differential diagnoses and identifying coexisting pathology, such as partial ruptures, bursitis, paratendonitis, plantaris involvement, and/or fascial tears. 53, 60, 133, 137 Research studies on patients with midportion Achilles tendinopathy commonly use imaging techniques to examine the severity of ten- presumably related to physical status and the extent of injury and inflammatory activity that is present. Diagnosis of tissue irritability as acute or nonacute, according to the signs, symptoms, and duration of the condition, is important in guiding the clinical decisions regarding the intervention strategies as outlined in component 5.
Component 4
Outcome measures include an assessment of the patient's functional level and associated physical impairments as outlined in the FIGURE. Standardized tools, such as the VISA-A, FAAM, and LEFS, can be used for measuring a specific domain, whether it is a body structure or function, activity limitation, or participation restriction. Outcome measures are important in direct management of individual patient care, and they provide the opportunity to collectively compare care and determine effectiveness through the repeated application of standardized measurement.
Component 5
Intervention strategies outline criteria for treatment selection based on diagnostic indicators and clinical examination findings and allow for treatment planning based on re-evaluation. Interventions are grouped based on the following categories: therapeutic exercise (exercise, stretching, neuromuscular education), manual therapy, education (patient education, patient counseling), home use of medical supplies (bracing), and clinical use of medical devices (iontophoresis). A higher level of evidence indicates greater scientific support for the recommendation, not necessarily the intervention itself. For example, there is a relatively high-level of evidence for the recommendation not to use night splints for patients with midportion Achilles tendinopathy. Interventions outside of the scope of physical therapy, including corticosteroid injection, extracorporeal shockwave therapy (ESWT), and platelet-rich plasma (PRP) injections, are included as education for patients who are seeking additional treatment options. Of note, the majority of studies include patients with chronic midportion Achilles tendinopathy. Therefore, treatment of a patient with acute Achilles tendinopathy may depend more on clinical judgment and expert opinion. • Lower-quarter musculoskeletal and biomechanical assessment, to include the following elements of gait F -First metatarsophalangeal joint range of motion and accessory mobility: to attain 65° of extension at preswing -Tibialis posterior strength and movement coordination to control midtarsal joint motion at loading response -Talocrural dorsiflexion range of motion, accessory mobility, gastrocnemius/soleus muscle length, and tissue mobility to attain 10° of dorsiflexion at terminal stance -Gastrocnemius/soleus strength and movement coordination to control tibial advancement at midstance and propulsion at terminal stance -Hip joint mobility and muscle flexibility to attain 10° of extension at terminal stance -Trunk, buttock, and thigh muscle strength and movement coordination to control lower-limb internal rotation at loading response, and hip adduction at loading response and midstance
FIGURE (CONTINUED).
Model of diagnosis, examination, and treatment of Achilles pain, stiffness, and muscle power deficits. Superscript letters indicate that the guidelines are based on (A) strong evidence, (B) moderate evidence, (C) weak evidence, (D) conflicting evidence, (E) theoretical/foundational evidence, or (F) expert opinion.
OUTCOME MEASURES -ACTIVITY LIMITATIONS/ SELF-REPORTED MEASURES 2010 Recommendation
A
Clinicians should incorporate validated functional outcome measures, such as the Victorian Institute of Sport Assessment-Achilles (VISA-A) and the Foot and Ankle Ability Measure (FAAM). These should be utilized before and after interventions intended to alleviate the impairments of body function and structure, activity limitations, and participation restrictions associated with Achilles tendinopathy.
Evidence Update
I
Iversen et al 97 provided evidence of validity and reliability for the VISA-A questionnaire in Danishspeaking individuals.
II
The VISA-A has been validated for patients with Achilles tendinopathy who speak Turkish 57 and French. 103 The validity and reliability findings in these studies are consistent with the results reported in the previously published Achilles tendinopathy guideline.
22
II
Systematic reviews have assessed the evidence to support outcome measures for those with lowerleg, ankle, and foot conditions. 136, 181 The Lower Extremity Functional Scale (LEFS) and FAAM were found to be most commonly used, with the FAAM receiving the highest quality assessment score for responsiveness. 181 A separate systematic review found evidence of reliability, validity, and responsiveness to support the LEFS for individuals with lower-limb musculoskeletal conditions.
136
Recommendation
A
Clinicians should use the VISA-A to assess pain and stiffness, and either the FAAM or the LEFS to assess activity and participation in patients with a diagnosis of midportion Achilles tendinopathy. 
ACTIVITY LIMITATIONS/PHYSICAL PERFORMANCE MEASURES
2010 Recommendation B When evaluating functional limitations over an episode of care for those with Achilles tendinopathy, measures of activity limitation and participation restriction can include objective and reproducible assessment of the ability to walk, descend stairs, perform unilateral heel raises, single-limb hop,
Recommendation
B
Clinicians should use physical performance measures, including hop and heel-raise endurance tests as appropriate, to assess a patient's functional status and document findings.
PHYSICAL IMPAIRMENT MEASURES
Recommended impairment measures and their properties are provided in the 2010 CPG.
22 See the FIGURE in the 2010 CPG for the summary of recommended physical impairment measures.
and 2018 Recommendation
B
When evaluating physical impairment over an episode of care for those with Achilles tendinopathy, one should measure ankle dorsiflexion range of motion, subtalar joint range of motion, plantar flexion strength and endurance, static arch height, forefoot alignment, and pain with palpation.
CLINICAL GUIDELINES Examination
A systematic search of the literature did not reveal articles to alter the 2010 recommendations for iontophoresis, manual therapy, or heel lifts in the treatment of midportion Achilles tendinopathy. Updated recommendations are provided for exercise, which includes eccentric, eccentric/concentric, and heavy-load, slow-speed protocols; stretching; night splints; low-level laser therapy (LLLT); orthoses; taping; neuromuscular re-education; and dry needling. Although corticosteroid injection, ESWT, and PRP injections are used as interventions for those with Achilles tendinopathy, they are outside the scope of physical therapy practice, and therefore only summaries are provided for patient education purposes.
EXERCISE 2010 Recommendation
A
Clinicians should consider implementing an eccentric loading program to decrease pain and improve function in patients with midportion Achilles tendinopathy.
Evidence Update
I
In a systematic review by Sussmilch-Leitch et al, 192 9 randomized controlled trials, all published before 2009, directly studied eccentric exercise. This systematic review supported the use of eccentric exercise for midportion Achilles tendinopathy.
Beyer et al 14 found similar outcomes for a heavyload, slow-speed exercise and an eccentric training protocol. The heavy-load, slow-speed exercise protocol included 3 bilateral full-range-of-motion heel-raise exercises performed at a speed of 6 seconds per repetition as follows: (1) flexed knee on a seated calf-raise machine, (2) extended knee with the barbell on shoulders, and (3) extended knee on a leg-press machine. The 12-week program included increasing weight with progressively decreasing repetitions. The dosages per week were as follows: week 1, 3 sets of 15 repetitions; weeks 2 and 3, 3 sets of 12 repetitions; weeks 4 and 5, 4 sets of 10 repetitions; weeks 6 to 8, 4 sets of 8 repetitions; and weeks 9 to 12, 4 sets of 6 repetitions. 
II
Although several systematic reviews supported eccentric exercises, heterogeneity across exercise protocols was identified, including factors such as maximum load, speed of contraction, and frequency of sessions not being adequately controlled.
71,87,130, 168 Malliaras et al 131 noted that trials often did not isolate eccentric from concentric contractions, and therefore questioned the need for an eccentriconly exercise protocol. However, Frizziero et al 71 found eccentric training to be more effective than concentric exercises, general therapeutic exercise, and ESWT. It should be noted that compliance with eccentric training (27%-72%) 87 and outcomes were found to vary considerably across studies.
71,87,130,168
II
A randomized controlled trial (n = 80, 20 per group) examined daily eccentric exercise (twice per day, 7 days per week) compared to twice weekly eccentric exercise (once per day, twice per week). 196 At 12 weeks, the differences in the VISA-A score between the daily exercise and twice-weekly eccentric exercise groups were not significant.
Stevens and Tan
190 compared 2 intensities of the Alfredson eccentric protocol in a small sample (13-15 per group) of patients. Those in the "do as tolerated" group completed an average of 112 repetitions daily, while those in the "protocol" group averaged 166 repetitions. No significant differences between groups were found on pain VAS or VISA-A scores at 6 weeks.
IV
The case series study by Ram et al 158 evaluated the responses of 16 of 20 participants with chronic midportion Achilles tendinopathy who had tried at least 1 other treatment to a 12-week eccentric training program. Despite experiencing improved scores on the VISA-A, pain VAS, and Tegner activity scale, only 2 participants were satisfied with treatment. Compared to other studies, the low satisfaction may have to do with the fact that patients had a chronic condition and had tried other treatments.
14 CLINICAL GUIDELINES
Interventions
IV
de Vos et al 48 examined changes in tendon structure using a specific ultrasonic tissue characterization approach before and after a 16-week eccentric exercise program. The changes defined by the ultrasonic tissue characterization approach found no association between collagen type and VISA-A scores at any time point.
Several randomized controlled trials compared eccentric exercise combined with other interventions to eccentric exercise alone. 41, 49, 50, 147, 165, 196, 197, 212, 215 The observed changes in the control groups (eccentric exercise alone) provide useful information. Improvement in symptom severity (VISA-A) across studies varied in these control groups from 2.4% at 8 weeks, 215 212 the results were equivalent to eccentric exercise alone. However, when eccentric exercise was combined with LLLT, 196 ESWT, 165 or acupuncture, 215 studies favored the combined treatments.
It should be noted that studies have excluded participants with presumed frailty of the tendon structure because of metabolic or genetic diseases and drugs. Therefore, little is known about risks and benefits of eccentric exercise for these patients.
Because specific factors (eg, frequency, load, and speed) are not standardized across studies, the optimum parameters for exercise are yet to be formulated.
Recommendation
A
Clinicians should use mechanical loading, which can be either in the form of eccentric or a heavyload, slow-speed (concentric/eccentric) exercise program, to decrease pain and improve function for patients with midportion Achilles tendinopathy without presumed frailty of the tendon structure. 
Evidence Update
IV
A study by Verrall et al 203 evaluated a single cohort of patients performing a 6-week stretching program that was described as an "eccentric stretching" protocol. One set required participants to perform 9 plantar flexor stretches (6 with knee straight and 3 with knee bent) off the end of a step. Each "heel drop" stretch was held for 15 to 20 seconds. Participants increased from 1 set to 3 and from bilateral to the involved side over a 6-week period. Pain decreased on a 0-to-10 VAS scale from 7.2 at baseline to 2.9 at 12 weeks. Eighty-two percent of participants reported a level of satisfaction of 7/10 or greater with treatment.
Recommendation
C
Clinicians may use stretching of the ankle plantar flexors with the knee flexed and extended to reduce pain and improve satisfaction with outcome in patients with midportion Achilles tendinopathy who exhibit limited ankle dorsiflexion range of motion.
NEUROMUSCULAR RE-EDUCATION 2010 Recommendation
No recommendation.
Evidence Update
IV
Neuromuscular control among runners with midportion Achilles tendinopathy has been examined in several case-control studies.
10,13,70 Running studies identified patterns of decreased lower extremity muscle activity in participants with midportion Achilles tendinopathy compared to a control group. 10,13,70 However, it is unclear whether decreased muscle activity is a cause or a result of midportion Achilles tendinopathy, and whether an intervention targeting these altered patterns of muscle activity improve outcomes.
Recommendation
F
Clinicians may use neuromuscular exercises targeting lower extremity impairments that may lead to abnormal kinetics and/or kinematics, specifically eccentric overload of the Achilles tendon during weight-bearing activities.
MANUAL THERAPY 2010 Recommendation
F
Clinicians may use joint and soft tissue mobilization to reduce pain and improve mobility and function in patients with midportion Achilles tendinopathy.
Recommendation
E
Clinicians may counsel patients with midportion Achilles tendinopathy. Key elements of patient counseling could include (1) theories supporting use of physical therapy and role of mechanical loading; (2) modifiable risk factors, including BMI and shoewear; and (3) typical time course for recovery from symptoms.
HEEL LIFTS 2010 and 2018 Recommendation
D
Because contradictory evidence exists, no recommendation can be made for the use of heel lifts in patients with midportion Achilles tendinopathy.
NIGHT SPLINTS 2010 Recommendation
C
Night splints are not beneficial in reducing pain when compared to eccentric exercise in patients with Achilles tendinopathy.
Evidence Update
I
A systematic review by Sussmilch-Leitch et al 192 found 2 studies with conflicting results on the additional effect of night splints added to an eccentric exercise program. A pooled meta-analysis found that a night splint provided no significant additional improvement in patient-reported symptoms (VISA-A) at 12 weeks.
II
A 1-year follow-up randomized controlled trial found no additional benefit of a night splint to eccentric exercise. 40 There were no significant differences in symptom severity (VISA-A) between groups at baseline or 3-month and 1-year follow-ups. There were also no significant differences between groups in morning stiffness or patient satisfaction at 1-year follow-up.
Recommendation
C
Clinicians should not use night splints to improve symptoms in patients with midportion Achilles tendinopathy.
ORTHOSES 2010 Recommendation
C
A foot orthosis can be used to reduce pain and alter ankle and foot kinematics while running in patients with Achilles tendinopathy.
Evidence Update
V
Cheatham et al 27 looked at the efficacy of soft tissue mobilization in a systematic review. Although there were no studies specific to those with midportion Achilles tendinopathy, there appeared to be some evidence supporting instrument-augmented soft tissue mobilization for improving motion in a limited number of studies.
Recommendation
F
Clinicians may consider using joint mobilization to improve mobility and function and soft tissue mobilization to increase range of motion for patients with midportion Achilles tendinopathy
PATIENT EDUCATION: ACTIVITY MODIFICATION 2010 Recommendation
Evidence Update
I
Silbernagel et al 182 compared the effects of continued sports activity (eg, running and jumping activities below a specified pain intensity) to active rest while patients completed an exercise program for midportion Achilles tendinopathy. Patients in the active rest group could choose to swim, run in deep water, bike, or walk as a daily activity. The specific guideline was for patients to maintain pain levels below a 5/10 on a VAS for all activities. All participants performed a standardized exercise program. Both groups significantly improved on the VISA-A at 5-year follow-up, with the mean VISA-A scores greater than 90 for both groups. 182 
Recommendation
B
For patients with nonacute midportion Achilles tendinopathy, clinicians should advise that complete rest is not indicated and that they should continue with their recreational activity within their pain tolerance while participating in rehabilitation.
PATIENT COUNSELING 2010 Recommendation
Evidence Update
V
There is no direct evidence that patient counseling benefits patients with Achilles tendinopathy. However, patient education and counseling are both considered important for patient care. 168, 182 Evidence Update
II
Two systematic reviews noted no effect of orthoses for patients with midportion Achilles tendinopathy.
130,168
I
Munteanu et al 139 examined the effects of a custom orthosis compared with a sham orthosis. All participants also performed an eccentric exercise program. No difference was found in VISA-A scores at baseline and at 1, 3, 6, and 12 months between the 2 groups.
Recommendation
D
Because contradictory evidence exists, no recommendation can be made for the use of orthoses in patients with midportion Achilles tendinopathy.
TAPING 2010 Recommendation
F
Taping may be used in an attempt to decrease strain on the Achilles tendon in patients with Achilles tendinopathy.
Evidence Update
IV
A systematic review noted that 1 of 2 low-level studies supported taping for midportion Achilles tendinopathy. 168 
A case-control study 66 examined the immediate effects of therapeutic elastic tape applied to the Achilles tendon and found application of tape did not improve hop distance or decrease pain.
Recommendation
F
Clinicians should not use therapeutic elastic tape to reduce pain or improve functional performance in patients with midportion Achilles tendinopathy.
Clinicians may use rigid taping to decrease strain on the Achilles tendon and/or alter foot posture in patients with midportion Achilles tendinopathy.
LOW-LEVEL LASER THERAPY 2010 Recommendation
B
Clinicians should consider the use of LLLT to decrease pain and stiffness in patients with Achilles tendinopathy.
Evidence Update
II
Tumilty and colleagues 197 compared LLLT to placebo laser treatment while both groups concurrently participated in an eccentric exercise program. The laser parameters were set at 810 nm, 100-mW infrared probe, at 3.0 J per point (18 J per session). The LLLT group did not have clinically or statistically greater improvement in the numeric pain-rating scale or symptom severity (VISA-A) at baseline and at 4, 12, and 52 weeks.
Hutchison et al
95 compared LLLT to a placebo laser treatment using a laser probe, with a spectrum of 530 nm to 1100 nm, to administer a single pulse of 39 J. There were no differences between groups in symptom severity (VISA-A), pain (VAS), or function (LEFS) at baseline and at 6 or 12 weeks. In addition, at 12 weeks, neither group demonstrated a significant difference from baseline in patientreported outcome measures (95% CI of difference from baseline: VISA-A, -7.2, 7.2; VAS, -15.8, 9.6; LEFS, -4.44, 7.33).
II
A randomized trial (n = 80, 20 per group) examined 2 different exercise regimens and the ability of laser to supplement these programs. 196 The 4 arms of the study included placebo plus daily exercise, LLLT plus daily exercise, placebo plus twice-weekly exercise, and LLLT plus twice-weekly exercise. The key significant finding at 12 weeks was that the combination of LLLT plus twice-weekly exercise resulted in the greatest improvement in symptom severity over the 12-week period, as measured by the VISA-A (mean improvement, 18.5% [95% CI: 9.1%, 27.9%]), achieving an average score near the ceiling of the VISA-A (score, 99). In addition, differences between placebo plus daily exercise and LLLT plus daily exercise, although not significant, favored LLLT plus daily exercise by an average of 8.2% (95% CI: -1.3%, 17.7%). Although only the results for LLLT plus twiceweekly exercise were significant, the study was underpowered to determine whether laser was better than no laser. This leaves open the possibility that laser may have significant effects not just for specific exercise protocols but across different exercise protocols.
Recommendation
D
Because contradictory evidence exists, no recommendation can be made for the use of LLLT in patients with midportion Achilles tendinopathy.
IONTOPHORESIS 2010 and 2018 Recommendation
B
Clinicians should use iontophoresis with dexamethasone to decrease pain and improve function in patients with acute midportion Achilles tendinopathy.
DRY NEEDLING 2010 Recommendation
Evidence Update
III
In a recent prospective cohort study, 206 comparisons were made between high-volume image-guided injection (HVIGI) with and without dry needling. Participants in the HVIGI-only group improved an average of 33.4 points on the VISA-A, while the participants in the HVIGI and dry needling group on average only improved by 6.9 points.
IV
In a case series study by Yeo et al, 213 participants received tendon injection of marcaine (tendon decompression) followed by dry needling in conjunction with a 4-week eccentric exercise program. Pain VAS scores (0-100) during rest and activity decreased by 24% and 39.1%, respectively, at 6 weeks post procedure. At 12 and 24 months, 77% and 76% of participants, respectively, had high or very high satisfaction levels.
Recommendation
F
Clinicians may use combined therapy of dry needling with injection under ultrasound guidance and eccentric exercise to decrease pain for individuals with symptoms greater than 3 months and increased tendon thickness.
INTERVENTIONS OUTSIDE THE SCOPE OF PHYSICAL THERAPY
Summaries were not provided in 2010 for corticosteroid injection, ESWT, and PRP injections.
CORTICOSTEROID INJECTION 2018 Summary
A systematic review of randomized controlled trials of corticosteroid injections for all types of tendinopathy concluded that an initial short-term benefit is not maintained at intermediate and long-term follow-up. 32 Although the risk of a tendon rupture is low, other minor complications are more common, including postinjection pain, subcutaneous atrophy, and skin depigmentation. 32 Patients with Achilles tendinopathy who did not respond to exercises alone received up to 3 glucocorticosteroid injections (76% received at least 1 injection) in this observational study (midportion tendinopathy, n = 75; insertional tendinopathy, n = 18). 205 Patients managed with either exercise alone or a combination of exercise and glucocorticosteroid injections had good outcomes in this cohort at 6 months (94% reported improvement and 77% reported an excellent or good result). 59, 205 Similarly, in a recent randomized controlled study and systematic review, participants who received high-volume corticosteroid injections coupled with eccentric exercises demonstrated an improvement of 29 points in their VISA-A at 24 weeks, while those in the exercise-only group improved 11 points.
17,26
EXTRACORPOREAL SHOCKWAVE THERAPY 2018 Summary
Extracorporeal shockwave therapy, when combined with eccentric exercise for chronic midportion Achilles tendinopathy, is supported in some systematic reviews with improvement in VISA-A score, pain, and function. 71, 81, 130, 168, 192 The only systematic review to perform a meta-analysis noted no effect favoring ESWT alone. However, qualitative evidence favors ESWT when combined with eccentric exercise. 192 Two case series also provide low-level evidence in support of the use of ESWT. 174, 194 Saxena et al 174 demonstrated significant improvement with ESWT on a ranking of daily and recreational activities at 1-year follow-up, with a total of 78% of the patients considering themselves improved. Taylor et al 194 studied ESWT in patients with midportion Achilles tendinopathy who did not respond to initial therapy (average length of symptoms of 20 months). At 2-year follow-up, patients demonstrated an improvement in the VISA-A from 40 at baseline to 66. 194 However, there was no difference in pain VAS between baseline and the 2-year follow-up. In summary, there is evidence that ESWT benefits patients with chronic midportion Achilles tendinopathy when combined with eccentric exercise. Evidence supporting ESWT alone and optimal dosage (eg, high versus low energy) is unclear.
PLATELET-RICH PLASMA INJECTION 2018 Summary
Many systematic reviews determined that high-level evidence does not support the use of PRP injections for a variety of outcomes, including VISA-A, return to sport, ultrasound measures, and function (eg, FAAM), for individuals with midportion Achilles tendinopathy. In press. https://doi.org/10.1007/s00167-017-4710-8
46. 
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